Multiple Sclerosis Intimacy and Sexuality Questionnaire
NCT ID: NCT05374031
Last Updated: 2022-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
130 participants
OBSERVATIONAL
2021-08-12
2022-03-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: The study included 130 women with MS. The Turkish linguistic validation process of the original English MSISQ-15 was performed according to standardized guidelines. Reliability analysis was evaluated with test-retest analysis and intra-class correlation (ICC). Internal consistency between the items was analyzed using the Cronbach's alpha coefficient. Item analysis results were used to assess the contribution of the items to the scale. In evaluating the validity of the scale, the relationship between the MSISQ and the Female Sexual Function Index (FSFI), the Multiple Sclerosis Quality of Life Questionnaire-54 (MSQOL-54), and the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PSIQ-12) was investigated. Psychometric properties were analyzed using internal consistency, test-rest reliability, construct validity, and floor-ceiling effect.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reliability and Validity of the Turkish Version of the Multiple Sclerosis Knowledge Questionnaire
NCT03927092
Investigation of the Effectiveness of Structured Education According to Premenstrual Syndrome Symptom Map
NCT06585475
Motivational Interviewing-Based Training
NCT06972030
The Effect of Therapeutic Communication Program on the Psychological State of Children
NCT06275711
Effectiveness of Interpersonal Relationship Psychotherapy Intervention for Female Victims of Intimate Partner Violence
NCT06687278
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
descriptive study
descriptive study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* who did not have any mental problems preventing cooperation and understanding,
* who were diagnosed with MS
Exclusion Criteria
* having a history of relapse in the past 30 days;
* experiencing loss of balance or gait disturbance caused by a condition other than MS;
* being pregnant; having a history of gynecological, urological and/or neurological surgery;
* having a history of cesarean or vaginal birth in the past six months;
* being sexually inactive; and, having urinary tract infections
19 Years
64 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bozok University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
hanife dogan
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yozgat Bozok University
Yozgat, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-KAEK 189
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.